Article Versions Notes

Ashoorzadeh A, Mowday AM, Guise CP, Silva S, Bull MR, Abbattista MR, Copp JN, Williams EM, Ackerley DF, Patterson AV, et al. Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications. Pharmaceuticals. 2022; 15(2):185. https://doi.org/10.3390/ph15020185

Ashoorzadeh, Amir, Alexandra M. Mowday, Christopher P. Guise, Shevan Silva, Matthew R. Bull, Maria R. Abbattista, Janine N. Copp, Elsie M. Williams, David F. Ackerley, Adam V. Patterson, and et al. 2022. "Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications" Pharmaceuticals 15, no. 2: 185. https://doi.org/10.3390/ph15020185

Ashoorzadeh, A., Mowday, A. M., Guise, C. P., Silva, S., Bull, M. R., Abbattista, M. R., Copp, J. N., Williams, E. M., Ackerley, D. F., Patterson, A. V., & Smaill, J. B. (2022). Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications. Pharmaceuticals, 15(2), 185. https://doi.org/10.3390/ph15020185